Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sytske Anne Bergstra

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Current Opinion in Rheumatology|January 23, 2018
What is the optimal target for treat-to-target strategies in rheumatoid arthritis?Sytske Anne Bergstra, Cornelia F Allaart
Seminars in Arthritis and Rheumatism|January 13, 2024
Why most (but perhaps not all) DMARDs work equally wellRobert B M Landewé, Alexandre Sepriano, Sytske Anne Bergstra
RMD Open|June 7, 2019
Three handy tips and a practical guide to improve your propensity score modelsSytske Anne Bergstra, Alexandre Sepriano, Sofia Ramiro, et al.
Rheumatology (Oxford, England)|September 29, 2017
Rheumatoid arthritis patients with continued low disease activity have similar outcomes over 10 years, regardless of initial therapySytske Anne Bergstra, Robert B M Landewé, Tom W J Huizinga, et al.
Rheumatology (Oxford, England)|April 30, 2021
The association between increased body mass index and response to conventional synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: results from the METEOR databaseMrinalini Dey, Sizheng S Zhao, Robert J Moots, et al.
Annals of the Rheumatic Diseases|May 29, 2021
Glucocorticoid discontinuation in patients with early rheumatoid and undifferentiated arthritis: a post-hoc analysis of the BeSt and IMPROVED studiesJohanna Maria Maassen, Raquel Dos Santos Sobrín, Sytske Anne Bergstra, et al.
Clinical and Experimental Rheumatology|October 21, 2016
Ten years of METEOR (an international rheumatoid arthritis registry): development, research opportunities and future perspectivesSytske Anne Bergstra, Pedro M M C Machado, Rosaline van den Berg, et al.
The Journal of Rheumatology|June 17, 2018
Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR RegisterSytske Anne Bergstra, Cornelia F Allaart, Sofia Ramiro, et al.
Annals of the Rheumatic Diseases|July 8, 2018
Inequity in access to bDMARD care and how it influences disease outcomes across countries worldwide: results from the METEOR-registrySytske Anne Bergstra, Jaime C Branco, David Vega-Morales, et al.
RMD Open|June 8, 2020
Body mass index and treatment survival in patients with RA starting treatment with TNFα-inhibitors: long-term follow-up in the real-life METEOR registrySytske Anne Bergstra, Cornelia F Allaart, David Vega-Morales, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Current Opinion in Rheumatology|January 23, 2018
What is the optimal target for treat-to-target strategies in rheumatoid arthritis?Sytske Anne Bergstra, Cornelia F Allaart
Seminars in Arthritis and Rheumatism|January 13, 2024
Why most (but perhaps not all) DMARDs work equally wellRobert B M Landewé, Alexandre Sepriano, Sytske Anne Bergstra
RMD Open|June 7, 2019
Three handy tips and a practical guide to improve your propensity score modelsSytske Anne Bergstra, Alexandre Sepriano, Sofia Ramiro, et al.
Rheumatology (Oxford, England)|September 29, 2017
Rheumatoid arthritis patients with continued low disease activity have similar outcomes over 10 years, regardless of initial therapySytske Anne Bergstra, Robert B M Landewé, Tom W J Huizinga, et al.
Rheumatology (Oxford, England)|April 30, 2021
The association between increased body mass index and response to conventional synthetic disease-modifying anti-rheumatic drug treatment in rheumatoid arthritis: results from the METEOR databaseMrinalini Dey, Sizheng S Zhao, Robert J Moots, et al.
Annals of the Rheumatic Diseases|May 29, 2021
Glucocorticoid discontinuation in patients with early rheumatoid and undifferentiated arthritis: a post-hoc analysis of the BeSt and IMPROVED studiesJohanna Maria Maassen, Raquel Dos Santos Sobrín, Sytske Anne Bergstra, et al.
Clinical and Experimental Rheumatology|October 21, 2016
Ten years of METEOR (an international rheumatoid arthritis registry): development, research opportunities and future perspectivesSytske Anne Bergstra, Pedro M M C Machado, Rosaline van den Berg, et al.
The Journal of Rheumatology|June 17, 2018
Sex-associated Treatment Differences and Their Outcomes in Rheumatoid Arthritis: Results from the METEOR RegisterSytske Anne Bergstra, Cornelia F Allaart, Sofia Ramiro, et al.
Annals of the Rheumatic Diseases|July 8, 2018
Inequity in access to bDMARD care and how it influences disease outcomes across countries worldwide: results from the METEOR-registrySytske Anne Bergstra, Jaime C Branco, David Vega-Morales, et al.
RMD Open|June 8, 2020
Body mass index and treatment survival in patients with RA starting treatment with TNFα-inhibitors: long-term follow-up in the real-life METEOR registrySytske Anne Bergstra, Cornelia F Allaart, David Vega-Morales, et al.
Pageof 6